Xuhai Jonathan Lu

Xuhai Jonathan Lu is a Principal Scientist at Ferring Pharmaceuticals since February 2023, with a prior role as Principal Scientist at Sampled, where leadership included editing human iPSC cells with CRISPR. Experience spans multiple positions in research, including Senior Scientist and Scientist roles at InVitro Cell Research, and a Research Scientist position at Texas Heart Institute, overseeing cardiovascular research and investigating lipoprotein chemistry in metabolic conditions. Xuhai Jonathan Lu's background also includes significant contributions at Baylor College of Medicine as a Research Associate and Lab Manager, focusing on atherosclerosis and innovating mass spectrometry techniques. Educational qualifications include a Master’s degree in Biology from the University of Houston and a Doctor of Medicine from Hunan Medical University.